Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...
Advances in genome editing are transforming the treatment for rare genetic diseases, as seen in the case of seven-month-old ...
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...
Breakthroughs in RNA editing and radioligand therapies are poised to take biotech into a new era – driving innovation, growth and new investment opportunities Biotechnology is entering a dynamic new ...
On June 28, 2012, the most significant scientific breakthrough of the first quarter of the 21st century was announced to the ...
From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...
Prosper Junior Bakiny has positions in Alphabet, Amazon, and Vertex Pharmaceuticals. The Motley Fool has positions in and ...
Researchers have unveiled a new DNA-based therapy that silences the PCSK9 gene to lower cholesterol without statin side ...
Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...
Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...
Despite setbacks and funding cuts — and a quieting of the hype blaring its arrival — multiple CRISPR-based trials are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback